Lista de obras - Lorena Landuzzi - Dominio Público Uruguay

A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy

artículo científico publicado en 2018

A multi-DNA preventive vaccine for p53/Neu-driven cancer syndrome

artículo científico publicado en 2009

An anti-apoptotic role for NGF receptors in human rhabdomyosarcoma

artículo científico publicado en 2001

An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas.

artículo científico publicado en 2014

Antimetastatic Activity of a Preventive Cancer Vaccine

artículo científico publicado en 2007

Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity

artículo científico publicado en 2004

Biological indicators of prognosis in Ewing's sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP).

artículo científico publicado en 2010

C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.

artículo científico publicado en 2003

CD99 acts as an oncosuppressor in osteosarcoma

artículo científico publicado en 2006

Cancer Vaccines Co-Targeting HER2/Neu and IGF1R.

artículo científico publicado en 2019

Cancer immunoprevention: from mice to early clinical trials.

artículo científico publicado en 2018

Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers

artículo científico publicado en 2014

Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cells

artículo científico publicado en 1993

Endothelin-3 production by human rhabdomyosarcoma: a possible new marker with a paracrine role

artículo científico publicado en 2006

Enhancement of experimental metastatic ability by tumor necrosis factor-alpha alone or in combination with interferon-gamma.

artículo científico publicado en 1990

Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression

artículo científico publicado en 2021

Expression of HER/erbB family of receptor tyrosine kinases and induction of differentiation by glial growth factor 2 in human rhabdomyosarcoma cells

artículo científico publicado en 2000

Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells.

artículo científico publicado en 2002

Expression of interleukin 15 (IL-15) in human rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma

artículo científico publicado en 1997

Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas

artículo científico publicado en 2014

H-2Kb and H-2Db gene transfections in B16 melanoma differently affect non-immunological properties relevant to the metastatic process. Involvement of integrin molecules.

artículo científico publicado en 1994

HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines.

artículo científico publicado en 2011

High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.

artículo científico publicado en 2009

Human responses against HER-2-positive cancer cells in human immune system-engrafted mice

artículo científico publicado en 2012

Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells

artículo científico

Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis

artículo científico publicado en 2019

Immunological prevention of a multigene cancer syndrome

artículo científico publicado en 2004

Immunoprevention and immunotherapy of mammary carcinoma

artículo científico publicado en 2010

Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine

artículo científico publicado en 2004

In silico modeling and in vivo efficacy of cancer-preventive vaccinations.

artículo científico publicado en 2010

In vivo and in vitro production of haemopoietic colony-stimulating activity by murine cell lines of different origin: a frequent finding

article

Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells

artículo científico publicado en 2004

Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells

scholarly article

Inhibition of lung colonisation of a mouse mammary carcinoma by therapeutic vaccination with interferon-alpha gene-transduced tumor cells

artículo científico publicado en 1998

Inhibition of prostate carcinogenesis by combined active immunoprophylaxis

artículo científico publicado en 2007

Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma

scientific article published on 13 December 2021

Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice.

artículo científico publicado en 1998

Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis.

artículo científico publicado en 2015

Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug

artículo científico publicado en 2013

Molecular and cellular biology of rhabdomyosarcoma.

artículo científico publicado en 2009

Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor

artículo científico publicado en 2012

Murine model for skeletal metastases of Ewing's sarcoma

artículo científico publicado en 2000

Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs

artículo científico publicado en 1989

NVP-BEZ235 as a new therapeutic option for sarcomas.

artículo científico publicado en 2010

New target antigens for cancer immunoprevention

artículo científico publicado en 2005

OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis

scientific article published on 11 June 2018

Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4.

artículo científico publicado en 2009

Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma

scientific article published on 17 February 2021

Preclinical in vivo study of new insulin-like growth factor-I receptor--specific inhibitor in Ewing's sarcoma

artículo científico publicado en 2007

Preclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus.

artículo científico publicado en 2013

Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma

artículo científico publicado en 2013

Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12.

artículo científico publicado en 2003

Production of stem cell factor and expression of c-kit in human rhabdomyosarcoma cells: lack of autocrine growth modulation

artículo científico publicado en 1998

Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model system.

artículo científico publicado en 2010

Re: Randomized Trial of Adjuvant Human Interferon Gamma Versus Observation in High-Risk Cutaneous Melanoma: a Southwest Oncology Group Study

artículo científico publicado en 1996

Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy.

artículo científico publicado en 2009

Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy.

artículo científico publicado en 2011

The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kit

artículo científico publicado en 2000

Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-gamma

artículo científico publicado en 2001

Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice.

scientific article published on January 2014

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

artículo científico publicado en 2014

Vaccines and other immunological approaches for cancer immunoprevention

artículo científico publicado en 2011

Virus-like particle display of HER2 induces potent anti-cancer responses.

artículo científico publicado en 2018

Lista de obras de Lorena Landuzzi

A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy

A multi-DNA preventive vaccine for p53/Neu-driven cancer syndrome

An anti-apoptotic role for NGF receptors in human rhabdomyosarcoma

An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas.

Antimetastatic Activity of a Preventive Cancer Vaccine

Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity

Biological indicators of prognosis in Ewing's sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP).

C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.

CD99 acts as an oncosuppressor in osteosarcoma

Cancer Vaccines Co-Targeting HER2/Neu and IGF1R.

Cancer immunoprevention: from mice to early clinical trials.

Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers

Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cells

Endothelin-3 production by human rhabdomyosarcoma: a possible new marker with a paracrine role

Enhancement of experimental metastatic ability by tumor necrosis factor-alpha alone or in combination with interferon-gamma.

Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression

Expression of HER/erbB family of receptor tyrosine kinases and induction of differentiation by glial growth factor 2 in human rhabdomyosarcoma cells

Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells.

Expression of interleukin 15 (IL-15) in human rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma

Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas

H-2Kb and H-2Db gene transfections in B16 melanoma differently affect non-immunological properties relevant to the metastatic process. Involvement of integrin molecules.

HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines.

High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.

Human responses against HER-2-positive cancer cells in human immune system-engrafted mice

Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells

Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis

Immunological prevention of a multigene cancer syndrome

Immunoprevention and immunotherapy of mammary carcinoma

Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine

In silico modeling and in vivo efficacy of cancer-preventive vaccinations.

In vivo and in vitro production of haemopoietic colony-stimulating activity by murine cell lines of different origin: a frequent finding

Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells

Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells

Inhibition of lung colonisation of a mouse mammary carcinoma by therapeutic vaccination with interferon-alpha gene-transduced tumor cells

Inhibition of prostate carcinogenesis by combined active immunoprophylaxis

Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma

Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice.

Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis.

Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug

Molecular and cellular biology of rhabdomyosarcoma.

Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor

Murine model for skeletal metastases of Ewing's sarcoma

Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs

NVP-BEZ235 as a new therapeutic option for sarcomas.

New target antigens for cancer immunoprevention

OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis

Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4.

Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma

Preclinical in vivo study of new insulin-like growth factor-I receptor--specific inhibitor in Ewing's sarcoma

Preclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus.

Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma

Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12.

Production of stem cell factor and expression of c-kit in human rhabdomyosarcoma cells: lack of autocrine growth modulation

Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model system.

Re: Randomized Trial of Adjuvant Human Interferon Gamma Versus Observation in High-Risk Cutaneous Melanoma: a Southwest Oncology Group Study

Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy.

Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy.

The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kit

Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-gamma

Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice.

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

Vaccines and other immunological approaches for cancer immunoprevention

Virus-like particle display of HER2 induces potent anti-cancer responses.